chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: F
Vaccine: DTAPH, IPV, MMR
Symptoms: Dyspnoea, Hypersensitivity, Infection, Injection site erythema, Injection site vesicles
Clinical narrative: Patient's left shoulder started swelling a little on Wed., 5-12-04.  On Thur., 5-13-04 the swelling had gotten worse (meaning more of her arm down to her elbow was swelling up), blisters started to appear on her shoulder at the site where she had the vaccination.  The entire area was hot to the touch and very red.  I took her to the clinic and they said it was just a alergic reaction, and gave me samples of Dallergy to give her (1 tsp. 3 times daily for 3 days) Plus Motrin 2 1/2 tsp. twice daily for the fever.  On Friday night patient went with her father for the weekend, I copied him on all of her paper work.  He took her into ER Friday 5-14-04 night because she was shaking uncontrollably and said she felt like she could not breathe. They treated her at ER and then transported her to another hospital. I was not with her at this time, until I was able to meet them.  Hospital said she had an infection from the vaccination, and ER had given her an antibotic thru a I.V., then the other facility gave me a perscription for another antibotic.
Age: 5.0
Sex: F
Vaccine: DTAPH, IPV, MMR
Symptoms: Injection site warmth, Oedema peripheral, Tremor
Clinical narrative: Patient's left shoulder started swelling a little on Wed., 5-12-04.  On Thur., 5-13-04 the swelling had gotten worse (meaning more of her arm down to her elbow was swelling up), blisters started to appear on her shoulder at the site where she had the vaccination.  The entire area was hot to the touch and very red.  I took her to the clinic and they said it was just a alergic reaction, and gave me samples of Dallergy to give her (1 tsp. 3 times daily for 3 days) Plus Motrin 2 1/2 tsp. twice daily for the fever.  On Friday night patient went with her father for the weekend, I copied him on all of her paper work.  He took her into ER Friday 5-14-04 night because she was shaking uncontrollably and said she felt like she could not breathe. They treated her at ER and then transported her to another hospital. I was not with her at this time, until I was able to meet them.  Hospital said she had an infection from the vaccination, and ER had given her an antibotic thru a I.V., then the other facility gave me a perscription for another antibotic.
Age: 61.0
Sex: F
Vaccine: TD
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Lymphadenopathy
Clinical narrative: Patient received tetanus in left deltoid on 05/03/04.  Stated has had continued pain and swelling in arm since vaccination.  Redness with warmth noted inside of left arm and swollen lymph gland in left axilla.  Dneies fever.  No known history of allergy to tetanus.
Age: 21.0
Sex: F
Vaccine: ANTH, SMALL
Symptoms: Antinuclear antibody, Hypoaesthesia, Hypokinesia, Injection site pain, Injection site swelling
Clinical narrative: Patient is a 21-year-old who received her first Anthrax and primary Smallpox vaccination on 22 January 2004.  She demonstrates that she received her Anthrax in the LEFT tricep and Smallpox vaccination in her RIGHT deltoid.  She initially reports mild swelling and pain at each injection site but no substantial swelling or erythema occurring 7-10 days after her vaccinations.  Approximately 1 to 1 ½ weeks after immunizations, upon waking she noticed mild swelling in both her hands and wrists that ached with movement.  Associated symptoms included axillary lymphandenopathy, left greater than right, stiffness in neck, posteriorly and laterally, and difficulty removing rings from her hands. She was given her second Anthrax vaccination on 23Jan04. She again demonstrates vaccine given in the right tricep. Her previous symptoms persisted causing her to report to sick call on 2 February 2004 where she was advised that she was experiencing a mild reaction to immunizations and was prescribed Indocin 25mg 1-2 every 12 hours.    Her symptoms continued as a constant ache that never stopped.  The ache varied in intensity from 3-4/10 to 7/10 (today).  Movement, lifting, prolonged use of hands and arms triggers feelings of weakness, numbness and tingling that reportedly extended to her elbows, limiting her ability to work on board ship.  She was medi-vaced for further evaluation and treatment.
Age: 21.0
Sex: F
Vaccine: ANTH, SMALL
Symptoms: Laboratory test abnormal, Lymphadenopathy, Muscular weakness, Musculoskeletal stiffness, Oedema peripheral
Clinical narrative: Patient is a 21-year-old who received her first Anthrax and primary Smallpox vaccination on 22 January 2004.  She demonstrates that she received her Anthrax in the LEFT tricep and Smallpox vaccination in her RIGHT deltoid.  She initially reports mild swelling and pain at each injection site but no substantial swelling or erythema occurring 7-10 days after her vaccinations.  Approximately 1 to 1 ½ weeks after immunizations, upon waking she noticed mild swelling in both her hands and wrists that ached with movement.  Associated symptoms included axillary lymphandenopathy, left greater than right, stiffness in neck, posteriorly and laterally, and difficulty removing rings from her hands. She was given her second Anthrax vaccination on 23Jan04. She again demonstrates vaccine given in the right tricep. Her previous symptoms persisted causing her to report to sick call on 2 February 2004 where she was advised that she was experiencing a mild reaction to immunizations and was prescribed Indocin 25mg 1-2 every 12 hours.    Her symptoms continued as a constant ache that never stopped.  The ache varied in intensity from 3-4/10 to 7/10 (today).  Movement, lifting, prolonged use of hands and arms triggers feelings of weakness, numbness and tingling that reportedly extended to her elbows, limiting her ability to work on board ship.  She was medi-vaced for further evaluation and treatment.
Age: 21.0
Sex: F
Vaccine: ANTH, SMALL
Symptoms: Pain, Paraesthesia
Clinical narrative: Patient is a 21-year-old who received her first Anthrax and primary Smallpox vaccination on 22 January 2004.  She demonstrates that she received her Anthrax in the LEFT tricep and Smallpox vaccination in her RIGHT deltoid.  She initially reports mild swelling and pain at each injection site but no substantial swelling or erythema occurring 7-10 days after her vaccinations.  Approximately 1 to 1 ½ weeks after immunizations, upon waking she noticed mild swelling in both her hands and wrists that ached with movement.  Associated symptoms included axillary lymphandenopathy, left greater than right, stiffness in neck, posteriorly and laterally, and difficulty removing rings from her hands. She was given her second Anthrax vaccination on 23Jan04. She again demonstrates vaccine given in the right tricep. Her previous symptoms persisted causing her to report to sick call on 2 February 2004 where she was advised that she was experiencing a mild reaction to immunizations and was prescribed Indocin 25mg 1-2 every 12 hours.    Her symptoms continued as a constant ache that never stopped.  The ache varied in intensity from 3-4/10 to 7/10 (today).  Movement, lifting, prolonged use of hands and arms triggers feelings of weakness, numbness and tingling that reportedly extended to her elbows, limiting her ability to work on board ship.  She was medi-vaced for further evaluation and treatment.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Drug ineffective, Infection, Pruritus
Clinical narrative: Diagnosis: Varicella with vaccine 11/17/1998. 05/09/04-Tired--Less Active-No temp. taken  05/10/04-Red raised rash (torso and face)  05/11/04-Rash became vesicles  05/12/04-vesicles--various stages pustules mild puritis
Age: 18.0
Sex: M
Vaccine: SMALL
Symptoms: Injection site mass, Injection site oedema, Injection site pain, Injection site reaction, Keloid scar
Clinical narrative: 15 mm x 7 mm elevated nodule on right arm deltoid region at site of previous SPV.  Borders even.  Some inconsistency in coloration with faint hyperpigmented areas on nodule.  S/P Smallpox vaccination 02/02/03.  Diagnosis:  Keloid vs. dermatofibroma  HPI: Patient is a 20 yo male who received his primary smallpox vaccination on 02 Feb 2003.  He states that he attended the smallpox briefing and received the educational brochures.  Around the time of the vaccination, he does not recall any local or systemic problems other than perhaps mild flu-like symptoms for about a week.    He states that his primary SPV site healed normally except he had three scab formations at the site.  Approximately two weeks after the vaccination, he developed a scab, but it was inadvertently torn off when a medic took off his band-aid.  Approximately two weeks after this, he developed another scab, which was also inadvertently torn off.  One week later, he developed a third scab that fell off on its own.  He estimates that the remaining Jennerian scar was approximately 6 mm at that time.  He describes it as just a flat scar.  Approximately two months later, he noted that he was developing a bump at the site of the SPV.  He describes it as a puffy, non-pruritic, non-draining bump that he estimates was approximately 8 mm.  This area has gradually grown in size to a 15 mm elevated firm mass.  Although he states it is mostly non-tender, he does recall two occasions when he felt a stinging sensation at the site ("like he had been stung").  The stinging sensations lasted a couple of seconds, occurred when he was at rest, and he does not recall any injury or insect bite to the site.  He has a history of hypertrophic scar formation at the site of childhood scars on his right elbow, right wrist, and right lower abdominal area.  In addition, he has some elevated areas on at the site of tattoos on bilateral upper extremities.  In addition, he reports that his mother has a large elevated surgical (Cesarean section) scar on her abdomen.  He denies any personal or family history of skin cancer.  Patient has been referred to Dermatology.  Appointment pending at this time.
Age: 18.0
Sex: M
Vaccine: SMALL
Symptoms: Skin hyperpigmentation
Clinical narrative: 15 mm x 7 mm elevated nodule on right arm deltoid region at site of previous SPV.  Borders even.  Some inconsistency in coloration with faint hyperpigmented areas on nodule.  S/P Smallpox vaccination 02/02/03.  Diagnosis:  Keloid vs. dermatofibroma  HPI: Patient is a 20 yo male who received his primary smallpox vaccination on 02 Feb 2003.  He states that he attended the smallpox briefing and received the educational brochures.  Around the time of the vaccination, he does not recall any local or systemic problems other than perhaps mild flu-like symptoms for about a week.    He states that his primary SPV site healed normally except he had three scab formations at the site.  Approximately two weeks after the vaccination, he developed a scab, but it was inadvertently torn off when a medic took off his band-aid.  Approximately two weeks after this, he developed another scab, which was also inadvertently torn off.  One week later, he developed a third scab that fell off on its own.  He estimates that the remaining Jennerian scar was approximately 6 mm at that time.  He describes it as just a flat scar.  Approximately two months later, he noted that he was developing a bump at the site of the SPV.  He describes it as a puffy, non-pruritic, non-draining bump that he estimates was approximately 8 mm.  This area has gradually grown in size to a 15 mm elevated firm mass.  Although he states it is mostly non-tender, he does recall two occasions when he felt a stinging sensation at the site ("like he had been stung").  The stinging sensations lasted a couple of seconds, occurred when he was at rest, and he does not recall any injury or insect bite to the site.  He has a history of hypertrophic scar formation at the site of childhood scars on his right elbow, right wrist, and right lower abdominal area.  In addition, he has some elevated areas on at the site of tattoos on bilateral upper extremities.  In addition, he reports that his mother has a large elevated surgical (Cesarean section) scar on her abdomen.  He denies any personal or family history of skin cancer.  Patient has been referred to Dermatology.  Appointment pending at this time.
Age: 15.0
Sex: M
Vaccine: DT
Symptoms: Dizziness, Hyperhidrosis, Hypotension, Somnolence, Syncope
Clinical narrative: fainted, diaphoretic, became hypotensive, dizziness persisted after being in trendelenberg position >one hour, patient very sleepy following syncopal event
Age: 1.0
Sex: F
Vaccine: HIBV, MMR
Symptoms: Hypersensitivity, Injection site erythema, Injection site induration
Clinical narrative: 10 minutes after child received MMR #1, parent noted area of redness. Per provider an area of  6cm redness, 2cm induration, irregular in shape surrounding right anterolateral injection site. No other skin lesions noted. No respiratory distress noted. Per doctor's order, Benadryl 10mg po was given. Parent's of patient instructed to wait 1 hour. Parents instructed on signs of allergic reaction and importance to get medical attention.  Parents refused to wait and left clinic area.
Age: 34.0
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Drug ineffective, Infection, Injection site vesicles, Pyrexia
Clinical narrative: BROKE OUT WITH CHICKEN POX 7 TO 10 DAYS AFTER RECIEVING VACCINE. FIRST SIGN IS SORES AT THE INJECTION SITE. SLIGHT FEVER, THEN MORE BUMPS ON FACE, SCALP, BACK AND NECK AREA. WAS SEEN BY THE DOCTOR AND WAS GIVEN (ACYCLOVIR) MEDICATION TO SHORTEN THE VIRUS.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MM
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: PHONE CALL FROM CLIENTS PHYSICIAN REPORTING A LOCAL REACTION OF SWELLING, REDNESS AND WARMTH IN THE RIGHT UPPER ARM.
Age: 4.0
Sex: U
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: PT. RECEIVED DapTCELL VACCINE IN L. DELTOID. AFTER 48 HRS., PT RETURNED TO OFFICE TO HAVE PPD READ & PARENT STATED INJ. SITE OF DapTCELL BECAME RED, SWOLLEN, & WARM TO THE TOUCH. ON EXAM, ARM WAS NO LONGER SWOLLEN, ONLY SLIGHTLY PINK, NOT PAINFUL OR WARM TO TOUCH.THIS WAS 1ST.\ DOSE WITH DAPTACEL-PREVIOUS IMM.WITH TRIPEDIA.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: PT.RECEIVED DapTCELL VACCINE N L. DELTOID.AFTER 72HRS., PT. RETURNED TO OFFICE TO HAVE PPD READ & PARENT STATED INJ.SITE OF DapTCELL BECAME RED, SWOLLEN, & WARM TO TOUCH. ON EXAM ONLY SLIGHT PINK DEMARCATION. ALL PREVIOUS ADPT WERE TRIPEDIA
Age: 1.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, MMR, VARCEL
Symptoms: Skin discolouration, Swelling
Clinical narrative: SWELLING  AND DISCOLORATION RIGHT THIGH
Age: 47.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Laboratory test abnormal, Rash
Clinical narrative: Information has been received from a health professional concerning a 47 year old female patient with a history of hypertension nos and no illness at the time of vaccination who on 2/24/03 was vaccinated SC in the left upper arm with a first dose of varicella virus vaccine live (lot number 643080/0451M). Other medications included hydrochlorothiazide and valsartan. On 2/27/03 at 2:00 PM the patient developed a rash on the trunk and behind the ears. Laboratory diagnostic tests on 2/4/03 and 3/4/03 included a negative varicella titer and a repeat titer of pos 2.5, respectively. Subsequently, the patient recovered. No further information is expected.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Headache, Infection, Pharyngolaryngeal pain, Pyrexia
Clinical narrative: Information has been received from a licensed practical nurse concerning a 10 year old white female patient with no relevant medical history and no known allergies who on 23Aug2002 was vaccinated subcutaneously in the left arm with a first dose of varicella virus vaccine live. There was no illness at the time of vaccination and no symptoms following prior vaccinations. On 07Apr2003, the patient presented to the office with a sore throat, fever and a headache. On 08Apr2003, the patient was seen in the office for a "rash-diagnosed as probable chickenpox". On 09Apr2003, the patient presented to the office, at a different site, and was "diagnosed with chickenpox", also previously reported as a "full blown classic chickenpox rash", that was pruritic. It was noted that there were approximately "100-200 lesions all over" and in the mouth and ears. Treatment included acetaminophenj (APAP), diphenhydramine HCL (Benadryl), oatmeal baths and no prescription drugs were required. Subsequently, the patient recovered.  No further information is expected.
Age: 31.0
Sex: F
Vaccine: VARCEL
Symptoms: Medication error
Clinical narrative: Information has been received from a consumer who is a 31 year old female registered nurse with no relevant history and no laboratory data who on 05-Mar-2003 at 08:30 was accidentally exposed to varicella virus vaccine live (lot number 642680/0479M) while using a retractable syringe to administer the varicella vaccine to a 13 month-old male ("dad had a firm grip of child"). There was no illness at the time of exposure. It was reported that the vaccine splashed into both eyes and on face when retracting the needle. On 05-Mar-2003 at 08:30, it was noted that there was only mild stinging and the eyes were irrigated with contact solution, contacts were removed and discarded, face was washed and glasses were worn. on 06-Mar-2003, the following day, the patient saw and opthalmologist for "mild eye itching-Acute, mild bilateral conjuctivitis" and was treated with prescribed lubricating eye drops. It was reported that the patient recovered and her eyes felt "fine" by the date of this report" on 10 Mar 2003. No further information is expected.
Age: 1.0
Sex: M
Vaccine: DTAPHEPBIP, MMR, PNC, VARCEL
Symptoms: Pyrexia, Skin ulcer
Clinical narrative: Information has been received from a medical assistant concerning an 12 month old white male an amoxicillin allergy who on 4/3/03, at 11:30, was vaccinated with the first dose SC in the right arm of varicella virus vaccine live (lot # 644091/1066M). Concomitant vaccines that day at 11:30 included a first dose SC in the left arm of MMR (lot 643789/0876M), a first dose IM in the left leg of diphtheria toxoid (+) hepatitis B vaccine recombinant (+) pertussis vaccine (+) poliovirus vaccine inactivated (+) tetanus toxoid (lot 21188109) and a first dose IM in the right leg of Streptococcus pneumoniae vaccine (lot 491786). Other concomitant therapy included prednisone Na phosphate, cefpodoxime proxetil and hydrocortisone. The child had eczema at the time of vaccination. It was reported that the child was brought back to the office on 4/10/03 with dry lesions on his back, which the physician said could be possible shingles or chicken pox. The child was brought to the office again on 4/13/03 with a fever of 100 and 4-5 new lesions. The doctor diagnosed the lesions as chicken pox and prescribed acyclovir. Follow up information from the medical assistant indicated that the patient had a 3"x6" area on his back with dry lesions on the right flank (shingles). On 4/13/03 the patient had 45 new lesions that still looked like shingles or chickenpox. The report indicated that the patient recovered. No additional information is expected.
Age: 5.0
Sex: M
Vaccine: IPV, MMR, VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a health professional concerning a 5 year old white male with no medical history and no allergies who on 21JUL1998 the patient was also vaccinated with a first dose of measles virus vaccine live+mumps virus vaccine live dose of oral polio virus vaccine (manufacturer unknown). It was unknown if the patient had an illness at the time of vaccination. On 17APR2003 the patient was seen in the office with a bad case of chicken pox that had started to develop on 02APR2003. It was reported that there were "over 50 chicken pox rash seen". No lab or diagnostic studies were performed. It was also reported that there had been a serious outbreak of chicken pox in local schools. Unspecified medical attention was sought. Subsequently, the patient recovered. It was also noted that three other patients, two of whom are siblings of the above mentioned patient were vaccinated with a dose of varicella virus vaccine live and developed chicken pox (WAES 0304USA01957, 0304USA02419 and 0304USA02420). No further information is expected.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Rash vesicular, Viral infection
Clinical narrative: Information has been received from a health professional concerning an 8 year old white female with an unknown medical history who on 04FEB1997 was vaccinated with a dose of varicella virus vaccine live There was no illness at the time of vaccination. It was unknown if the patient was on concomitant medication. On 02APR2003 the patient was seen in the office with a very mild case of chicken pox with a small, cloudy filled fluid rash with clusters spreading all over her body and over 50 spots. No lab or diagnostic studies were performed. It was also reported that there had been a serious outbreak of chicken pox in local schools. It was also noted that three other patients, two of whom are siblings of the above mentioned patient, were vaccinated with a dose of varicella virus vaccine live and developed chicken pox. No further information is expected.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Rash vesicular, Viral infection
Clinical narrative: Information has been received from a licensed practical nurse concerning a nine year old white male patient with allergies and recurrent asthma who on 07SEP1995 was vaccinated in the right arm with a first dose of varicella virus vaccine live (lot no. 609286/0431B). There was no illness at the time of vaccination and there was no adverse events following prior vaccination. On 22APR2003, the patient developed a rash with less than 50 vesicles. On 23 APR2003, the patient presented to the doctor's office and was diagnosed with chickenpox. No treatment was reported and no laboratory tests were performed. Subsequently, the patient recovered. Additional information is not expected.
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Rash pustular, Rash vesicular
Clinical narrative: Information has been received from a physician and a licensed practical nurse concerning a 29 year old caucasian female with no allergies, medical conditions, or history of chickenpox who on 19MAR2003 t 9:15am was vaccinated SC in the left deltoid with a 0.5ml first dose of varicella virus vaccine live (lot 644086/0974M). There was no concomitant medication. There was no illness at the time of vaccination and there was no recent exposure to chicken pox or herpes zoster. The reporter indicated that on 01APR2003 the patient developed five vesicular lesions with wide distribution on her trunk and one on her ankle. No other symptoms were noted. On 02APR2003 the patient was noted to have a temperature of 100.6 but "feels fine." The reporter indicated that the patient's vesicles were not characteristic of varicella. Unspecified medical attention was sought. No presription drugs were required. Follow up information was received from a registered nurse which indicated that on approximately 31MAR2003 the patient developed five scattered, tiny, single, scabbed over pustules without erythema on the right shoulder, right and left chest wall, right hip and left ankle. It was noted that the rash was not pruritic. Vital signs were reported as T99.1 (reported as max temp)., BP 122/61, HR74, RR18. On a scale of zero to ten, with ten being the most, the patient rated her pain a zero. It was indicated that the patient recovered. There were no diagnostic tests or laboratory results. It was also stated that the patient had no adverse events following prior vaccination.
Age: 59.0
Sex: F
Vaccine: VARCEL
Symptoms: Facial palsy
Clinical narrative: Information has been received from a health professional concerning a 59 year old white female patient with hypertension nos and hypercholesterolemia who on 01NOV2002 was vaccinated subcutaneously (right  side injection site not specified) with a second dose of varicella virus vaccine live (lot 640491/0973L). There was no illness at the time of vaccination. Prior vaccinations included a subcutaneous (left side injection site not specified) first dose of varicella vaccine live on 17JUL2002 (lot 640071/1317L).  On 14NOV2002 the patient developed bells palsy. The patient visited her physician and was treated with prednisone (unspecified therapy) and pain medication. subsequently, the patient recovered. No further information is expected. The health professional also reported two other patients that were vaccinated with measles virus vaccine live+mumps virus vaccine live+rubella virus vaccine live+second generation MSD.
Age: 30.0
Sex: M
Vaccine: ANTH, ANTH, ANTH
Symptoms: Rash
Clinical narrative: This is a 52-year-old male who received Anthrax #1 on June 12, 2003. The following day he awoke and found that he had a reddened jagged line from his hairline to the corner of his eye then down the face to the chin. He reports that the line was approximately 1/16 of an inch in width. His initial thought was that the root canal he had two weeks prior had become infected. He had been on an antibiotic for about seven days following the root canal but had finished the antibiotic one-week prior to his anthrax vaccination. He reports that there was no pain, numbness or itching associated with this red line. He denies any mouth sores or a history of the same. Over the next few months he noted that the line moved slowly toward his nose. By September 12, when he received his 2nd anthrax vaccination, there was an area at his mouth that began to swell and developed purulent drainage. This reddened line migrated to the other side of his nose following anthrax #3 on November 1, 2003. He reports that as the line migrated from the right to the left side of the face, the right side would resolve. He reports that the skin was dry and flakey. He reports that he self-treated the purulent areas with Neosporin and used moisturizers on the dry areas. He went to physician for the first time on March 29, 2004. A surgeon initially saw him and his BP was 199/112. Then he went to see a family practice physician. At that time his BP was 161/83 and 150/78. The doctor stated that he initially thought he had shingles but that was not the case. He prescribed Bactroban cream 2% and told him to mix it with hydrocortisone cream 1% and apply it to his face three times daily. The areas at this time are over his lip the bridge of his nose and a couple of areas on his forehead. Some of the purulent areas are approximately the size of the end of his finger. He also reports that his left nostril is inflamed and this spreads into the inside of the nostril.
Age: 30.0
Sex: M
Vaccine: ANTH, ANTH, ANTH
Symptoms: Abscess, Dry skin, Erythema, Injection site inflammation, Skin striae
Clinical narrative: This is a 52-year-old male who received Anthrax #1 on June 12, 2003. The following day he awoke and found that he had a reddened jagged line from his hairline to the corner of his eye then down the face to the chin. He reports that the line was approximately 1/16 of an inch in width. His initial thought was that the root canal he had two weeks prior had become infected. He had been on an antibiotic for about seven days following the root canal but had finished the antibiotic one-week prior to his anthrax vaccination. He reports that there was no pain, numbness or itching associated with this red line. He denies any mouth sores or a history of the same. Over the next few months he noted that the line moved slowly toward his nose. By September 12, when he received his 2nd anthrax vaccination, there was an area at his mouth that began to swell and developed purulent drainage. This reddened line migrated to the other side of his nose following anthrax #3 on November 1, 2003. He reports that as the line migrated from the right to the left side of the face, the right side would resolve. He reports that the skin was dry and flakey. He reports that he self-treated the purulent areas with Neosporin and used moisturizers on the dry areas. He went to physician for the first time on March 29, 2004. A surgeon initially saw him and his BP was 199/112. Then he went to see a family practice physician. At that time his BP was 161/83 and 150/78. The doctor stated that he initially thought he had shingles but that was not the case. He prescribed Bactroban cream 2% and told him to mix it with hydrocortisone cream 1% and apply it to his face three times daily. The areas at this time are over his lip the bridge of his nose and a couple of areas on his forehead. Some of the purulent areas are approximately the size of the end of his finger. He also reports that his left nostril is inflamed and this spreads into the inside of the nostril.
Age: 30.0
Sex: M
Vaccine: ANTH, ANTH, ANTH
Symptoms: Swelling
Clinical narrative: This is a 52-year-old male who received Anthrax #1 on June 12, 2003. The following day he awoke and found that he had a reddened jagged line from his hairline to the corner of his eye then down the face to the chin. He reports that the line was approximately 1/16 of an inch in width. His initial thought was that the root canal he had two weeks prior had become infected. He had been on an antibiotic for about seven days following the root canal but had finished the antibiotic one-week prior to his anthrax vaccination. He reports that there was no pain, numbness or itching associated with this red line. He denies any mouth sores or a history of the same. Over the next few months he noted that the line moved slowly toward his nose. By September 12, when he received his 2nd anthrax vaccination, there was an area at his mouth that began to swell and developed purulent drainage. This reddened line migrated to the other side of his nose following anthrax #3 on November 1, 2003. He reports that as the line migrated from the right to the left side of the face, the right side would resolve. He reports that the skin was dry and flakey. He reports that he self-treated the purulent areas with Neosporin and used moisturizers on the dry areas. He went to physician for the first time on March 29, 2004. A surgeon initially saw him and his BP was 199/112. Then he went to see a family practice physician. At that time his BP was 161/83 and 150/78. The doctor stated that he initially thought he had shingles but that was not the case. He prescribed Bactroban cream 2% and told him to mix it with hydrocortisone cream 1% and apply it to his face three times daily. The areas at this time are over his lip the bridge of his nose and a couple of areas on his forehead. Some of the purulent areas are approximately the size of the end of his finger. He also reports that his left nostril is inflamed and this spreads into the inside of the nostril.
Age: 30.0
Sex: M
Vaccine: ANTH, ANTH, ANTH
Symptoms: Blood pressure increased, Dry skin, Eczema, Erythema, Periorbital oedema
Clinical narrative: This is a 52-year-old male who received Anthrax #1 on June 12, 2003. The following day he awoke and found that he had a reddened jagged line from his hairline to the corner of his eye then down the face to the chin. He reports that the line was approximately 1/16 of an inch in width. His initial thought was that the root canal he had two weeks prior had become infected. He had been on an antibiotic for about seven days following the root canal but had finished the antibiotic one-week prior to his anthrax vaccination. He reports that there was no pain, numbness or itching associated with this red line. He denies any mouth sores or a history of the same. Over the next few months he noted that the line moved slowly toward his nose. By September 12, when he received his 2nd anthrax vaccination, there was an area at his mouth that began to swell and developed purulent drainage. This reddened line migrated to the other side of his nose following anthrax #3 on November 1, 2003. He reports that as the line migrated from the right to the left side of the face, the right side would resolve. He reports that the skin was dry and flakey. He reports that he self-treated the purulent areas with Neosporin and used moisturizers on the dry areas. He went to physician for the first time on March 29, 2004. A surgeon initially saw him and his BP was 199/112. Then he went to see a family practice physician. At that time his BP was 161/83 and 150/78. The doctor stated that he initially thought he had shingles but that was not the case. He prescribed Bactroban cream 2% and told him to mix it with hydrocortisone cream 1% and apply it to his face three times daily. The areas at this time are over his lip the bridge of his nose and a couple of areas on his forehead. Some of the purulent areas are approximately the size of the end of his finger. He also reports that his left nostril is inflamed and this spreads into the inside of the nostril.
Age: 30.0
Sex: M
Vaccine: ANTH, ANTH, ANTH
Symptoms: Rash, Skin exfoliation, Skin striae, Swelling
Clinical narrative: This is a 52-year-old male who received Anthrax #1 on June 12, 2003. The following day he awoke and found that he had a reddened jagged line from his hairline to the corner of his eye then down the face to the chin. He reports that the line was approximately 1/16 of an inch in width. His initial thought was that the root canal he had two weeks prior had become infected. He had been on an antibiotic for about seven days following the root canal but had finished the antibiotic one-week prior to his anthrax vaccination. He reports that there was no pain, numbness or itching associated with this red line. He denies any mouth sores or a history of the same. Over the next few months he noted that the line moved slowly toward his nose. By September 12, when he received his 2nd anthrax vaccination, there was an area at his mouth that began to swell and developed purulent drainage. This reddened line migrated to the other side of his nose following anthrax #3 on November 1, 2003. He reports that as the line migrated from the right to the left side of the face, the right side would resolve. He reports that the skin was dry and flakey. He reports that he self-treated the purulent areas with Neosporin and used moisturizers on the dry areas. He went to physician for the first time on March 29, 2004. A surgeon initially saw him and his BP was 199/112. Then he went to see a family practice physician. At that time his BP was 161/83 and 150/78. The doctor stated that he initially thought he had shingles but that was not the case. He prescribed Bactroban cream 2% and told him to mix it with hydrocortisone cream 1% and apply it to his face three times daily. The areas at this time are over his lip the bridge of his nose and a couple of areas on his forehead. Some of the purulent areas are approximately the size of the end of his finger. He also reports that his left nostril is inflamed and this spreads into the inside of the nostril.
Age: 54.0
Sex: F
Vaccine: FLU3, PPV, FLUX, PPV
Symptoms: Asthma, Atrioventricular block, Blood pressure increased, Condition aggravated, Cough
Clinical narrative: Information has been received from a 54 year old female consumer with an anxiety disorder and a history of cataract surgery and foot surgery who on 10/20/03 was vaccinated with pneumococcal 23v polysaccharide vaccine (Lot # 647039/0604N).  Concomitant therapy that day included influenza virus vaccine (unspecified). Other concomitant therapy included buspirone HC1 (Buspar), zolpidem tartrate (Ambien), divalproex sodium (Depakote), esomeprazole magnesium (Nexium), and alprazolam (Xanax). The pt noted that she was "in perfect health" at the time of vaccination. Subsequently, "approximately ten days later", the pt became sick.  Initially, she had a sore throat. Then the pt had congestion in her lungs, followed by problems breathing, wheezing, running nose, and ear infections.  It was reported that "to date, her condition (was) somewhat better", however she continued to suffer from wheezing, congestion, breathing problems and she became fatigued more easily. She said that she had been treated with unspecified antibiotics, steroids, and inhalers.  It was noted that the pt had no history of allergic reactions. At the time of the report, the pt was "recovering with sequelae."  Follow up information received from a RN in the pt's doctor's office reported that "this pt was the only one who has had any complaints after vaccinations".  The office reportedly gave ">400 flu vaccines but don't know how many (pneumococcal 23v polysaccharide vaccine) vaccinations."  It was reported that "no one else has had any problems or complaints."  While consumer considered sickness of sore throat, congestion in her lungs, problems breathing, wheezing, running nose, ear infections, and fatigue to be disabling. Additional information has been requested. The pt reported previously contacting the CDC and VAERS and was reportedly given VAERS ID 218400. Follow up on 05/25/04 states: "Addittional follow up information included the lot # and manufacturer of the influenza virus vaccine. The consumer considered sickness of sore throat, congestion in her lungs, problems breathing, wheezing, runnning nose, ear infections and fatigue to be disabling. Additional information has been requested. The pt reported previously contacting the CDC and VAERS and was reportedly given VID 218400."
Age: 54.0
Sex: F
Vaccine: FLU3, PPV, FLUX, PPV
Symptoms: Dyspnoea, Influenza like illness, Nasal congestion, Pharyngolaryngeal pain, Pulmonary congestion
Clinical narrative: Information has been received from a 54 year old female consumer with an anxiety disorder and a history of cataract surgery and foot surgery who on 10/20/03 was vaccinated with pneumococcal 23v polysaccharide vaccine (Lot # 647039/0604N).  Concomitant therapy that day included influenza virus vaccine (unspecified). Other concomitant therapy included buspirone HC1 (Buspar), zolpidem tartrate (Ambien), divalproex sodium (Depakote), esomeprazole magnesium (Nexium), and alprazolam (Xanax). The pt noted that she was "in perfect health" at the time of vaccination. Subsequently, "approximately ten days later", the pt became sick.  Initially, she had a sore throat. Then the pt had congestion in her lungs, followed by problems breathing, wheezing, running nose, and ear infections.  It was reported that "to date, her condition (was) somewhat better", however she continued to suffer from wheezing, congestion, breathing problems and she became fatigued more easily. She said that she had been treated with unspecified antibiotics, steroids, and inhalers.  It was noted that the pt had no history of allergic reactions. At the time of the report, the pt was "recovering with sequelae."  Follow up information received from a RN in the pt's doctor's office reported that "this pt was the only one who has had any complaints after vaccinations".  The office reportedly gave ">400 flu vaccines but don't know how many (pneumococcal 23v polysaccharide vaccine) vaccinations."  It was reported that "no one else has had any problems or complaints."  While consumer considered sickness of sore throat, congestion in her lungs, problems breathing, wheezing, running nose, ear infections, and fatigue to be disabling. Additional information has been requested. The pt reported previously contacting the CDC and VAERS and was reportedly given VAERS ID 218400. Follow up on 05/25/04 states: "Addittional follow up information included the lot # and manufacturer of the influenza virus vaccine. The consumer considered sickness of sore throat, congestion in her lungs, problems breathing, wheezing, runnning nose, ear infections and fatigue to be disabling. Additional information has been requested. The pt reported previously contacting the CDC and VAERS and was reportedly given VID 218400."
Age: 54.0
Sex: F
Vaccine: FLU3, PPV, FLUX, PPV
Symptoms: Respiratory tract infection, Upper respiratory tract infection, Weight increased
Clinical narrative: Information has been received from a 54 year old female consumer with an anxiety disorder and a history of cataract surgery and foot surgery who on 10/20/03 was vaccinated with pneumococcal 23v polysaccharide vaccine (Lot # 647039/0604N).  Concomitant therapy that day included influenza virus vaccine (unspecified). Other concomitant therapy included buspirone HC1 (Buspar), zolpidem tartrate (Ambien), divalproex sodium (Depakote), esomeprazole magnesium (Nexium), and alprazolam (Xanax). The pt noted that she was "in perfect health" at the time of vaccination. Subsequently, "approximately ten days later", the pt became sick.  Initially, she had a sore throat. Then the pt had congestion in her lungs, followed by problems breathing, wheezing, running nose, and ear infections.  It was reported that "to date, her condition (was) somewhat better", however she continued to suffer from wheezing, congestion, breathing problems and she became fatigued more easily. She said that she had been treated with unspecified antibiotics, steroids, and inhalers.  It was noted that the pt had no history of allergic reactions. At the time of the report, the pt was "recovering with sequelae."  Follow up information received from a RN in the pt's doctor's office reported that "this pt was the only one who has had any complaints after vaccinations".  The office reportedly gave ">400 flu vaccines but don't know how many (pneumococcal 23v polysaccharide vaccine) vaccinations."  It was reported that "no one else has had any problems or complaints."  While consumer considered sickness of sore throat, congestion in her lungs, problems breathing, wheezing, running nose, ear infections, and fatigue to be disabling. Additional information has been requested. The pt reported previously contacting the CDC and VAERS and was reportedly given VAERS ID 218400. Follow up on 05/25/04 states: "Addittional follow up information included the lot # and manufacturer of the influenza virus vaccine. The consumer considered sickness of sore throat, congestion in her lungs, problems breathing, wheezing, runnning nose, ear infections and fatigue to be disabling. Additional information has been requested. The pt reported previously contacting the CDC and VAERS and was reportedly given VID 218400."
Age: 54.0
Sex: F
Vaccine: FLU3, PPV, FLUX, PPV
Symptoms: Dyspnoea, Fatigue, Lung disorder, Malaise, Nasal congestion
Clinical narrative: Information has been received from a 54 year old female consumer with an anxiety disorder and a history of cataract surgery and foot surgery who on 10/20/03 was vaccinated with pneumococcal 23v polysaccharide vaccine (Lot # 647039/0604N).  Concomitant therapy that day included influenza virus vaccine (unspecified). Other concomitant therapy included buspirone HC1 (Buspar), zolpidem tartrate (Ambien), divalproex sodium (Depakote), esomeprazole magnesium (Nexium), and alprazolam (Xanax). The pt noted that she was "in perfect health" at the time of vaccination. Subsequently, "approximately ten days later", the pt became sick.  Initially, she had a sore throat. Then the pt had congestion in her lungs, followed by problems breathing, wheezing, running nose, and ear infections.  It was reported that "to date, her condition (was) somewhat better", however she continued to suffer from wheezing, congestion, breathing problems and she became fatigued more easily. She said that she had been treated with unspecified antibiotics, steroids, and inhalers.  It was noted that the pt had no history of allergic reactions. At the time of the report, the pt was "recovering with sequelae."  Follow up information received from a RN in the pt's doctor's office reported that "this pt was the only one who has had any complaints after vaccinations".  The office reportedly gave ">400 flu vaccines but don't know how many (pneumococcal 23v polysaccharide vaccine) vaccinations."  It was reported that "no one else has had any problems or complaints."  While consumer considered sickness of sore throat, congestion in her lungs, problems breathing, wheezing, running nose, ear infections, and fatigue to be disabling. Additional information has been requested. The pt reported previously contacting the CDC and VAERS and was reportedly given VAERS ID 218400. Follow up on 05/25/04 states: "Addittional follow up information included the lot # and manufacturer of the influenza virus vaccine. The consumer considered sickness of sore throat, congestion in her lungs, problems breathing, wheezing, runnning nose, ear infections and fatigue to be disabling. Additional information has been requested. The pt reported previously contacting the CDC and VAERS and was reportedly given VID 218400."
Age: 54.0
Sex: F
Vaccine: FLU3, PPV, FLUX, PPV
Symptoms: Otitis media, Pharyngolaryngeal pain, Rhinorrhoea, Wheezing
Clinical narrative: Information has been received from a 54 year old female consumer with an anxiety disorder and a history of cataract surgery and foot surgery who on 10/20/03 was vaccinated with pneumococcal 23v polysaccharide vaccine (Lot # 647039/0604N).  Concomitant therapy that day included influenza virus vaccine (unspecified). Other concomitant therapy included buspirone HC1 (Buspar), zolpidem tartrate (Ambien), divalproex sodium (Depakote), esomeprazole magnesium (Nexium), and alprazolam (Xanax). The pt noted that she was "in perfect health" at the time of vaccination. Subsequently, "approximately ten days later", the pt became sick.  Initially, she had a sore throat. Then the pt had congestion in her lungs, followed by problems breathing, wheezing, running nose, and ear infections.  It was reported that "to date, her condition (was) somewhat better", however she continued to suffer from wheezing, congestion, breathing problems and she became fatigued more easily. She said that she had been treated with unspecified antibiotics, steroids, and inhalers.  It was noted that the pt had no history of allergic reactions. At the time of the report, the pt was "recovering with sequelae."  Follow up information received from a RN in the pt's doctor's office reported that "this pt was the only one who has had any complaints after vaccinations".  The office reportedly gave ">400 flu vaccines but don't know how many (pneumococcal 23v polysaccharide vaccine) vaccinations."  It was reported that "no one else has had any problems or complaints."  While consumer considered sickness of sore throat, congestion in her lungs, problems breathing, wheezing, running nose, ear infections, and fatigue to be disabling. Additional information has been requested. The pt reported previously contacting the CDC and VAERS and was reportedly given VAERS ID 218400. Follow up on 05/25/04 states: "Addittional follow up information included the lot # and manufacturer of the influenza virus vaccine. The consumer considered sickness of sore throat, congestion in her lungs, problems breathing, wheezing, runnning nose, ear infections and fatigue to be disabling. Additional information has been requested. The pt reported previously contacting the CDC and VAERS and was reportedly given VID 218400."
Age: 0.17
Sex: F
Vaccine: DTAP, HIBV, IPV, DTAP, HIBV, IPV
Symptoms: Unevaluable event
Clinical narrative: From initial information received on 5/11/04 from a health care professional regarding an adverse event occurring in the USA, it was reported that a two month old female patient received her first dose of ActHIB, lot number UE096AA, administered in the left thigh, her first dose of Daptacel, lot number C1612AA, administered in the left thigh and her first dose of IPOL, administered in the right thigh on 2/10/04. At approximately 5:00 AM the next morning the patient was found dead.  An autopsy was performed, the physician's office is sending a certified letter requesting results. The physician's office will forward a copy to the manufacturer once it's received. Reportedly, the local sherriff's office quarantined the sharps container and the vaccine lots involved.  Follow up on 11/01/04 states: "From additional information received on 11/01/04 from the initial reporter, it was reported, "Reviewed, no additional information at this time." From additional information redceived on 11/8/04 from the initial reporter, the information has reportedly been reviewed on 11/4/04 and additional information is availale at this time.